Plasma Therapies

HA380

Haemoperfusion Cartridge

Product Description

The HA380 is a Haemoperfusion cartridge that can be used as a stand alone device or in conjunction with other other extra-corporeal therapies.

The HA380 has the ability to remove pro-inflammatory cytokines in cytokine storm and other cellular inflammatory markers.

Clinical Indications Include:

  • Patients unresponsive to vasopressor support after fluid resuscitation
  • Hyper-lactataemia not responding to standard of care
  • COVID-19 rescue therapy (2 + 1 + 1 therapy) See publication 1
  • Patients unresponsive to standard of care who have multiple organ failure
  • Patients exhibiting signs of Damage Associated Molecular Patterns (DAMPS) or Pathogen Associated Molecular Patterns (PAMPS)
  • Intra-operative cardiac surgery where the patient already has significant pre-existing cellular inflammatory activation caused by  Heart Failure or where a VAD device has been implanted etc.
  • Patients requiring long pump procedures such as Heart / Lung transplant and other procedures.
  • Respiratory failure
  • Conjunctive therapy with ECMO

Request a free demonstration

Using the Jafron Adsorber in COVID-19 Patients
Organ Crosstalk in Critical Illness

Technical Details:

Product parameter   HA380
  Loading capacity (ml)   380±3
  Volume (ml)   150±5
  Absorbent material   Styrene divinybenzene copolymers
  Housing material   Polycarbonate
  Sterilization method   Irradiation sterilization
  Packaging size   290mm(L)×105mm(W)×105mm(H) 0.90kg

Request a free demonstration

Related Products
Interested in this product?

Request a call-back